1 Min Read
* Says received FDA 510(k) clearance for U.S. Market launch of its Optiflow Arterial Cannulae Family Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.